201 related articles for article (PubMed ID: 19517779)
21. Comparison of Efficacy and Side Effects of Oral Baclofen Versus Tizanidine Therapy with Adjuvant Botulinum Toxin Type A in Children With Cerebral Palsy and Spastic Equinus Foot Deformity.
Dai AI; Aksoy SN; Demiryürek AT
J Child Neurol; 2016 Feb; 31(2):184-9. PubMed ID: 25999301
[TBL] [Abstract][Full Text] [Related]
22. Use of botulinum toxin type A in pediatric patients with cerebral palsy: a three-center retrospective chart review.
Gormley ME; Gaebler-Spira D; Delgado MR
J Child Neurol; 2001 Feb; 16(2):113-8. PubMed ID: 11292216
[TBL] [Abstract][Full Text] [Related]
23. Neurophysiological changes induced by the botulinum toxin type A injection in children with cerebral palsy.
Frascarelli F; Di Rosa G; Bisozzi E; Castelli E; Santilli V
Eur J Paediatr Neurol; 2011 Jan; 15(1):59-64. PubMed ID: 20493744
[TBL] [Abstract][Full Text] [Related]
24. [Botulinum toxin in the treatment of cerebral palsy: case conference].
Nezu A; Adachi M
No To Hattatsu; 2012 May; 44(3):225-7. PubMed ID: 22712224
[No Abstract] [Full Text] [Related]
25. The key-muscle concept: a long-term low-dose injection strategy for botulinum toxin A treatment in cerebral palsy.
Placzek R; Salem KH; Meiss LA; Siebold D; Drescher W
Acta Orthop Belg; 2012 Feb; 78(1):111-6. PubMed ID: 22523937
[TBL] [Abstract][Full Text] [Related]
26. Application of botulinum toxin in treatment of spasticity and functional improvements for children suffering from cerebral palsy.
Meholjic A; Madjar D
Med Arh; 2010; 64(6):359-61. PubMed ID: 21218755
[TBL] [Abstract][Full Text] [Related]
27. Botulinum toxin a injection into calf muscles for treatment of spastic equinus in cerebral palsy: a controlled trial comparing sonography and electric stimulation-guided injection techniques: a preliminary report.
Kwon JY; Hwang JH; Kim JS
Am J Phys Med Rehabil; 2010 Apr; 89(4):279-86. PubMed ID: 20068435
[TBL] [Abstract][Full Text] [Related]
28. No change in calf muscle passive stiffness after botulinum toxin injection in children with cerebral palsy.
Alhusaini AA; Crosbie J; Shepherd RB; Dean CM; Scheinberg A
Dev Med Child Neurol; 2011 Jun; 53(6):553-8. PubMed ID: 21574991
[TBL] [Abstract][Full Text] [Related]
29. Effective results with botulinum toxin in cerebral palsy.
Coutinho dos Santos LH; Bufara Rodrigues DC; Simões de Assis TR; Bruck I
Pediatr Neurol; 2011 May; 44(5):357-63. PubMed ID: 21481744
[TBL] [Abstract][Full Text] [Related]
30. [Treatment of spasticity in children with cerebral palsy with botulinum toxin A].
Madsen ES; Sonne-Holm S; Wong C; Curtis D; Bencke J
Ugeskr Laeger; 2015 Jan; 177(3):V07140409. PubMed ID: 25613095
[TBL] [Abstract][Full Text] [Related]
31. Systemic adverse events following botulinum toxin A therapy in children with cerebral palsy.
Naidu K; Smith K; Sheedy M; Adair B; Yu X; Graham HK
Dev Med Child Neurol; 2010 Feb; 52(2):139-44. PubMed ID: 20412252
[TBL] [Abstract][Full Text] [Related]
32. [Development of motor functions and manual abilities in pediatric patients with spastic cerebral palsy after botulinum toxin treatment and complex rehabilitation].
Klochkova OA; Kurenkov AL; Namazova-Baranova LS; Mamed'iarov AM; Zherdev KV
Vestn Ross Akad Med Nauk; 2013; (11):38-48. PubMed ID: 24640730
[TBL] [Abstract][Full Text] [Related]
33. The role of botulinum toxin in the treatment of lower limb spasticity in children with cerebral palsy--a pilot study.
Zelnik N; Giladi N; Goikhman I; Keren G; Moris R; Honigman S
Isr J Med Sci; 1997 Feb; 33(2):129-33. PubMed ID: 9254875
[TBL] [Abstract][Full Text] [Related]
34. Botulinum toxin treatment in upper limb spasticity: treatment consistency.
Papavasiliou AS; Nikaina I; Bouros P; Rizou I; Filiopoulos C
Eur J Paediatr Neurol; 2012 May; 16(3):237-42. PubMed ID: 21862370
[TBL] [Abstract][Full Text] [Related]
35. Upper extremity function and occupational performance in children with spastic cerebral palsy following lower extremity botulinum toxin injections.
Keren-Capelovitch T; Jarus T; Fattal-Valevski A
J Child Neurol; 2010 Jun; 25(6):694-700. PubMed ID: 20508235
[TBL] [Abstract][Full Text] [Related]
36. Development of a framework to define the functional goals and outcomes of botulinum toxin A spasticity treatment relevant to the child and family living with cerebral palsy using the International Classification of Functioning, Disability and Health for Children and Youth.
Preston N; Clarke M; Bhakta B
J Rehabil Med; 2011 Nov; 43(11):1010-5. PubMed ID: 22031347
[TBL] [Abstract][Full Text] [Related]
37. [Therapeutic effects of different doses of botulinum toxin A injection on tiptoe deformation in children with cerebral palsy].
Niu GH; Zhang XL; Zhu DN; Cai ZJ; Li SS; Zhang W
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jul; 16(7):720-4. PubMed ID: 25008880
[TBL] [Abstract][Full Text] [Related]
38. [Treatment with botulinum toxin in neurologic pediatrics].
Justus N; Lee SH; Berweck S; Heinen F
Kinderkrankenschwester; 2007 Jul; 26(7):274-6. PubMed ID: 17726921
[No Abstract] [Full Text] [Related]
39. Botulinum toxin for the treatment of spasticity in children: attainment of treatment goals.
Weigl DM; Arbel N; Katz K; Becker T; Bar-On E
J Pediatr Orthop B; 2007 Jul; 16(4):293-6. PubMed ID: 17527109
[TBL] [Abstract][Full Text] [Related]
40. Effect of addition of botulinum toxin-A to standardized therapy for dynamic manual skills measured with kinematic aiming tasks in children with spastic hemiplegia.
Rameckers EA; Duysens J; Speth LA; Vles HJ; Smits-Engelsman BC
J Rehabil Med; 2010 Apr; 42(4):332-8. PubMed ID: 20461335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
